• Nachrichtendetail
• 

01.04.2024 17:05:00 - dpa-AFX: *VERTEX ANNOUNCES NEW DRUG SUBMISSION FOR EXAGAMGLOGENE AUTOTEMCEL ACCEPTED FOR PRIORITY REVIEW BY HEALTH CANADA

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	VERTEX PHARMAC. DL-,01	882807	Frankfurt	405,150	30.05.24 08:07:10	-5,150	-1,26%	405,300	407,300	405,150	410,300